Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin, Erbitux, and Irinotecan in 2nd Line Colorectal Cancer
NCT00681876Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Apr 2008
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC), sponsored by Hellenic Oncology Research Group. Started Apr 2008; status: terminated.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00681876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681876.